3 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18285800 | HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | Oct 05, 2023 |
| 18012278 | A COMBINATION OF A CBP/P300 BROMODOMAIN INHIBITOR AND AN EGFR INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLC | NOTTINGHAM, KYLE GREGORY | 1621 | Non-Final OA | Dec 22, 2022 |
| 16765419 | DIAGNOSTIC METHOD | BAUSCH, SARAE L | 1699 | Final Rejection | May 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial